SIMABS

SIMABS

Foundation date

22AUG2019

Sector

#Biotechnology / R&D Services

Subsector

• #Therapeutics - Biosimilars
• #Therapeutics - Proteins
• #Pharma - Nucleic acid drugs

Therapeutic areas

• #Conditions originating in the perinatal period
• #Neoplasms / cancer / oncology

SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.